BrightCoding · Jun 2026
Coverage of Ligo’s open-source AlphaFold3 implementation, custom GPU kernels, and early-stage research release.
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
San Francisco-based YC S24 biotech startup building AI tooling for programmable enzyme design. Ligo combines generative models, experimental feedback, and open-source biomolecular tooling to design novel enzymes and improve chemical manufacturing.
Primary product
AI-powered enzyme design models and programmable enzyme design tooling
Founded
2024
Headquarters
San Francisco, California, United States (HQ listed at 580 California Street, 12th & 16th Floors)
Team size
1-10
Industry
Biotechnology Research
Sub-industry
AI-driven enzyme design / computational biology
Offices
0 jobs at Ligo Biosciences
Check back later for new openings
Business model
Stage
Pre-seed
Total raised
$500K
Latest round
Pre-Seed · Sep 2024
Latest amount
$500K
Sep 2024 · Y Combinator
Leadership
CEO & Co-Founder
CSO & Founder
CTO & Co-Founder
Investors
Research-heavy and multidisciplinary, with a small team spanning biology, chemistry, mathematics, and computer science. Public materials emphasize open science, fast experimental feedback, and weekly enzyme-design iteration.
Compensation
No public salary bands found. Public hiring signals include flexible start dates and a $5,000 warm-intro bonus for a hire mentioned in LinkedIn posts.
Pricing
Not publicly disclosed; likely B2B partnerships / custom enzyme design engagements
Differentiators
Technology
Customers
Competitors
Estimated revenue
$440k-$513k estimated annual revenue
Estimated monthly visits
1.6K
BrightCoding · Jun 2026
Coverage of Ligo’s open-source AlphaFold3 implementation, custom GPU kernels, and early-stage research release.
Ligo Biosciences Blog · Jun 2026
Technical research note on optimizer scaling rules and geometric meaning in popular Muon implementations.
Ligo Biosciences Blog · May 2026
Technical research note from Arda Goreci on fold redundancy and why scaling natural sequences may not add as much structural diversity as expected.
Fondo · Feb 2026
Launch coverage describing Ligo’s generative enzyme design approach, target markets, and partnerships with Basecamp Research and Adaptyv Bio.
Sustainable Times · May 2025
Profiles Ligo’s enzyme-design mission, the founders’ Oxford/Y Combinator path, and the company’s open-science breakout around AlphaFold3.